NeuroCult™ Chemical Dissociation Kit (Mouse)

Kit for chemical dissociation of mouse neurospheres

New look, same high quality and support! You may notice that your instrument or reagent packaging looks slightly different from images displayed on the website, or from previous orders. We are updating our look but rest assured, the products themselves and how you should use them have not changed. Learn more

NeuroCult™ Chemical Dissociation Kit (Mouse)

Kit for chemical dissociation of mouse neurospheres

From: 195 USD
Catalog #
(Select a product)
Kit for chemical dissociation of mouse neurospheres
Add to Wish List

Product Advantages


  • Obtain cleaner cultures with non-mechanical and non-enzymatic cell dissociation

  • Achieve significantly higher cell viability and total cell number after expansion compared to trituration

  • Ensure minimal cell damage and maintained functional properties of cells

What's Included

  • NeuroCult™ Chemical Dissociation Solution A, 55 mL
  • NeuroCult™ Chemical Dissociation Solution B, 15 mL
  • NeuroCult™ Chemical Dissociation Solution C, 15 mL

Overview

Dissociate neurospheres derived from embryonic or adult mouse central nervous system tissue with NeuroCult™ Chemical Dissociation Kit. This gentle, non-mechanical and non-enzymatic dissociation kit results in minimal damage to the cells, and ensures higher cell variability and total cell number after expansion in comparison with trituration. Functional properties of cells dissociated with the NeuroCult™ Chemical Dissociation Kit are also maintained upon subsequent subculture.
Subtype
Non-Enzymatic
Cell Type
Neural Stem and Progenitor Cells
Species
Mouse
Application
Cell Culture
Brand
NeuroCult
Area of Interest
Neuroscience, Stem Cell Biology

Data Figures

Chemical Dissociation of Mouse Neurospheres

Figure 1. Chemical Dissociation of Mouse Neurospheres

Photomicrographs showing the chemical dissociation of mouse neurospheres at (A) 2 minutes (C) 5 minutes and (E) 7 minutes after the addition of NeuroCult™ Chemical Dissociation Solution B. Figures (B), (D) and (F) are enlargements of the boxed areas in figures (A), (C) and (E), respectively. A single cell suspension is evident in (E) and (F).

Comparison of Percent Viability and Cell Expansion Between the Neurocult™ Chemical Dissociation Kit and Trituration

Figure 2. Comparison of Percent Viability and Cell Expansion Between the Neurocult™ Chemical Dissociation Kit and Trituration

Mouse neurospheres were dissociated at each passage (up to P10) with the NeuroCult™ Chemical Dissociation Kit or trituration. Cells dissociated with the NeuroCult™ Chemical Dissociation Kit had a significantly higher percent viability and total cell number (after expansion) in comparison with trituration.

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Catalog #
05707
Lot #
All
Language
English
Document Type
Technical Manual
Catalog #
05707
Lot #
All
Language
English
Document Type
Safety Data Sheet 1
Catalog #
05707
Lot #
All
Language
English
Document Type
Safety Data Sheet 2
Catalog #
05707
Lot #
All
Language
English
Document Type
Safety Data Sheet 3
Catalog #
05707
Lot #
All
Language
English

Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

Resources and Publications

Publications (35)

Cathepsin B Improves ß-Amyloidosis and Learning and Memory in Models of Alzheimer's Disease. Embury CM et al. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2017 JUN

Abstract

Amyloid-ß (Aß) precursor protein (APP) metabolism engages neuronal endolysosomal pathways for Aß processing and secretion. In Alzheimer's disease (AD), dysregulation of APP leads to excess Aß and neuronal dysfunction; suggesting that neuronal APP/Aß trafficking can be targeted for therapeutic gain. Cathepsin B (CatB) is a lysosomal cysteine protease that can lower Aß levels. However, whether CatB-modulation of Aß improves learning and memory function deficits in AD is not known. To this end, progenitor neurons were infected with recombinant adenovirus expressing CatB and recovered cell lysates subjected to proteomic analyses. The results demonstrated Lamp1 deregulation and linkages between CatB and the neuronal phagosome network. Hippocampal injections of adeno-associated virus expressing CatB reduced Aß levels, increased Lamp1 and improved learning and memory. The findings were associated with the emergence of c-fos + cells. The results support the idea that CatB can speed Aß metabolism through lysosomal pathways and as such reduce AD-associated memory deficits.
DNA polymerase β decrement triggers death of olfactory bulb cells and impairs olfaction in a mouse model of Alzheimer's disease. Misiak M et al. Aging cell 2017 FEB

Abstract

Alzheimer's disease (AD) involves the progressive degeneration of neurons critical for learning and memory. In addition, patients with AD typically exhibit impaired olfaction associated with neuronal degeneration in the olfactory bulb (OB). Because DNA base excision repair (BER) is reduced in brain cells during normal aging and AD, we determined whether inefficient BER due to reduced DNA polymerase-β (Polβ) levels renders OB neurons vulnerable to degeneration in the 3xTgAD mouse model of AD. We interrogated OB histopathology and olfactory function in wild-type and 3xTgAD mice with normal or reduced Polβ levels. Compared to wild-type control mice, Polβ heterozygous (Polβ+/- ), and 3xTgAD mice, 3xTgAD/Polβ+/- mice exhibited impaired performance in a buried food test of olfaction. Polβ deficiency did not affect the proliferation of OB neural progenitor cells in the subventricular zone. However, numbers of newly generated neurons were reduced by approximately 25% in Polβ+/- and 3xTgAD mice, and by over 60% in the 3xTgAD/Polβ+/- mice compared to wild-type control mice. Analyses of DNA damage and apoptosis revealed significantly greater degeneration of OB neurons in 3xTgAD/Polβ+/- mice compared to 3xTgAD mice. Levels of amyloid β-peptide (Aβ) accumulation in the OB were similar in 3xTgAD and 3xTgAD/Polβ+/- mice, and cultured Polβ-deficient neurons exhibited increased vulnerability to Aβ-induced death. Olfactory deficit is an early sign in human AD, but the mechanism is not yet understood. Our findings in a new AD mouse model demonstrate that diminution of BER can endanger OB neurons, and suggest a mechanism underlying early olfactory impairment in AD.
Therapeutic potential of targeting microRNA-10b in established intracranial glioblastoma: first steps toward the clinic. Teplyuk NM et al. EMBO molecular medicine 2016 MAR

Abstract

MicroRNA-10b (miR-10b) is a unique oncogenic miRNA that is highly expressed in all GBM subtypes, while absent in normal neuroglial cells of the brain. miR-10b inhibition strongly impairs proliferation and survival of cultured glioma cells, including glioma-initiating stem-like cells (GSC). Although several miR-10b targets have been identified previously, the common mechanism conferring the miR-10b-sustained viability of GSC is unknown. Here, we demonstrate that in heterogeneous GSC, miR-10b regulates cell cycle and alternative splicing, often through the non-canonical targeting via 5'UTRs of its target genes, including MBNL1-3, SART3, and RSRC1. We have further assessed the inhibition of miR-10b in intracranial human GSC-derived xenograft and murine GL261 allograft models in athymic and immunocompetent mice. Three delivery routes for the miR-10b antisense oligonucleotide inhibitors (ASO), direct intratumoral injections, continuous osmotic delivery, and systemic intravenous injections, have been explored. In all cases, the treatment with miR-10b ASO led to targets' derepression, and attenuated growth and progression of established intracranial GBM. No significant systemic toxicity was observed upon ASO administration by local or systemic routes. Our results indicate that miR-10b is a promising candidate for the development of targeted therapies against all GBM subtypes.
New look, same high quality and support! You may notice that your instrument or reagent packaging looks slightly different from images displayed on the website, or from previous orders. We are updating our look but rest assured, the products themselves and how you should use them have not changed. Learn more